|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2010-8-16
|
|
pubmed:abstractText |
Patients with locally advanced pancreatic cancer (LAPC) are most commonly managed with chemotherapy or concurrent chemoradiotherapy (CRT), which may or may not include non-involved regional lymph nodes in the clinical target volume. We present our results of CRT for LAPC using capecitabine and delivering radiotherapy to a limited radiation field that excluded non-involved regional lymph nodes from the clinical target volume.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1433-2981
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright (c) 2010 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
570-7
|
|
pubmed:meshHeading |
pubmed-meshheading:20650619-Adenocarcinoma,
pubmed-meshheading:20650619-Aged,
pubmed-meshheading:20650619-Aged, 80 and over,
pubmed-meshheading:20650619-Antimetabolites, Antineoplastic,
pubmed-meshheading:20650619-Combined Modality Therapy,
pubmed-meshheading:20650619-Deoxycytidine,
pubmed-meshheading:20650619-Disease Progression,
pubmed-meshheading:20650619-Female,
pubmed-meshheading:20650619-Fluorouracil,
pubmed-meshheading:20650619-Humans,
pubmed-meshheading:20650619-Male,
pubmed-meshheading:20650619-Maximum Tolerated Dose,
pubmed-meshheading:20650619-Middle Aged,
pubmed-meshheading:20650619-Pancreatic Neoplasms,
pubmed-meshheading:20650619-Prodrugs,
pubmed-meshheading:20650619-Prospective Studies,
pubmed-meshheading:20650619-Radiotherapy Dosage,
pubmed-meshheading:20650619-Survival Rate,
pubmed-meshheading:20650619-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Efficacy and tolerability of limited field radiotherapy with concurrent capecitabine in locally advanced pancreatic cancer.
|
|
pubmed:affiliation |
Academic Radiation Oncology, The University of Manchester, Department of Medical Oncology, The Christie Hospital NHS Foundation Trust, Manchester, UK. Andrewjackson3@nhs.net
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
